|
| 海创药业-U(688302)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-10-13 | 1750.05 | 17.67% | 9901.56 | 0.00 | 7272.45 | 73.45% | 首发原股东限售股份 | | 2025-04-14 | 879.07 | 8.88% | 8151.51 | 1750.05 | 7272.45 | 73.45% | 首发原股东限售股份 | | 2024-04-12 | 99.04 | 1.00% | 7272.45 | 2629.11 | 2376.96 | 24.01% | 首发战略配售股份 | | 2023-09-28 | 1476.34 | 14.91% | 7173.41 | 2728.15 | 4284.63 | 43.27% | 首发原股东限售股份 | | 2023-08-31 | 1412.43 | 14.26% | 5697.06 | 4204.50 | 4284.63 | 43.27% | 首发原股东限售股份 | | 2023-06-15 | 1907.67 | 19.27% | 4284.63 | 5616.93 | 4284.63 | 43.27% | 首发原股东限售股份 | | 2022-10-12 | 113.59 | 1.15% | 2376.96 | 7524.60 | 2376.96 | 24.01% | 首发机构配售股份 | | 2022-04-12 | 2263.37 | 22.86% | 2263.37 | 7638.19 | 2263.37 | 22.86% | 首发一般股份 |
|